Pharmaceutical Manufacturing and Packing Sourcer |
 |
|
|
|
|
 |
| |
|
|
|
|
|
Industry Insight
Graham Hughes casts his eye over a selection of articles from this issue of PMPS. |
|
|
|
|
Technology Solutions
Brave New World
PMPS talks to Adam Crossno at OnAsset Intelligence about what attracted him to the pharmaceutical industry, the solutions that make the difference between success and failure, and his proudest moments. |
|
|
|
Supply Chain Integrity
Risk Mitigation: The Invisible Component of Cold Chain Management
Cold chain management is rapidly developing, and business improvements demonstrate the need for this to continue. Henry Ames at Sensitech highlights the invisible component to success in this area: risk mitigation. |
|
|
|
|
Smart Packaging
Flexible Pharma
Intelligence in packaging brings many benefits to both pharmaceutical companies and end users. Jeroen van den Brand at Holst Centre and Stuart Cherry at Pyramidion discuss two of the latest solutions.
|
|
|
|
Orally Dispersible Tablets
A Sweeter Deal
Liesbeth Meeus from Cargill Pharma explores the benefits and challenges of using erythritol as an excipient in ODTs, compared to other available options such as mannitol.
|
|
|
|
Ingredients & Formulation
A Matter of Taste
Taste-masking is an important growth area to overcome bitter-tasting APIs. Jon Fisher and Amie Gehris from The Dow Chemical Company focus on the use of complexation with ion exchange resins. |
|
|
|
Spray Drying
Fluid Motion
José Luis Santos and Márcio Temtem at Hovione reveal a new method of applying computational fluid dynamics to pharmaceutical spray drying, enhancing API performance. |
|
|
|
|
Packaging Sterilisation
Clean Sweep
Should packaging be given higher priority when a company chooses a method of sterilisation for a new product? Delphine Blondard from Top Clean Packaging Group and Sophie Rouif from Ionisos think so. |
|
|
|
Parenteral Delivery Devices
The Perfect Fit
Personalised medicine is the buzzword currently causing much debate within the industry. Andy Fry and Paul Greenhalgh at Team Consulting believe that truly tailored drug delivery devices are both possible and profitable.
|
|
|
|
Q&A: Drug Delivery
Future Investment
Jean-Marc Pardonge of Aptar Pharma puts forward what he believes should be priorities for innovation today, and predicts how the industry will change over the next decade. |
|
|
|
Q&A: Parenterals
Delivering Results
Discussing the latest developments in parenteral packaging, Dividella’s Stefan Knellwolf considers the market of today and forecasts the technology of tomorrow. |
|
|
|
|
Manufacturing Report
Lifting the Lid
A recent study commissioned by Siemens Industry asks UK manufacturers their opinions on a wide range of topical issues. Alan Johnston reports on the findings.
|
|
|
|
Serialisation
Track Back
Steve Wood at Covectra tackles the problem of prescription drug abuse in the US, and considers the use of serialisation as a tool for identifying those involved with drug diversion.
|
|
|
Falsified Medicines Directive
Act Now, Save Later
The new Falsified Medicines Directive is designed to combat counterfeit products across Europe - but can companies adapt without losing production time and costs? Simon Slater at Datamere Software Solutions investigates.
|
|
|
|
Generics Regulations
Quality Matters
The generics industry is faced with implementing a number of recent legislative changes. While quality is sure to improve, smaller manufacturers may struggle to keep up, says Michael Gamlen of Gamlen Tableting.
|
|
|
|
|
Book Reviews
Strategies for Success
Graham Hughes reviews two very different handbooks: one examining cleanrooms and the other a practical guide to packaging labelling and artwork. |
|
|
|
|
Blister Packaging Technology
The Future’s White
Using White Line technology to package small lots is the latest solution to a shift from high-volume products to low-volume ‘niche’ drugs, argues Körber Medipak’s Andrew Longworth.
|
|
|
|
Biopolymers
A Natural Choice
Full-scale commercialisation of biopolymers faces many obstacles, yet its major environmental benefits, among other key features, mean that it should not be ruled out, says Smithers Rapra Consultant, Michael Lock. |
|
|
|
|
Management & Operations
Smarter Supply Chains
Life sciences companies need to consider the current economic environment and make sensible choices regarding their supply chain operations, emphasises Heather Fraser at IBM. |
|
|
|
|
The End of the Line
Chain Reaction
Richard Harrop backs the benefits of good communication before even the smallest of decisions are made.
|
|
|
|
|
|
